I believe that Dr. Bosch’s talk this weekend at ASCO on solid tumors and Dr. Liau’s talk in September on the company, if only for 10 minutes, represent a pivot by the company from the GBM clinical trial results to education of the community that NWBO now has a product, DCVax, that’s applicable to all solid tumors.